Le Lézard
Classified in: Covid-19 virus
Subject: ATY

Levi & Korsinsky Notifies Extreme Networks, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - EXTR


NEW YORK, Sept. 20, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Extreme Networks, Inc. ("Extreme" or the "Company") (NASDAQ: EXTR) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Extreme investors who were adversely affected by alleged securities fraud between July 27, 2022 and January 30, 2024. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/extreme-networks-inc-lawsuit-submission-form?prid=103799&wire=4

EXTR investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (a) Extreme was suffering from adverse client demand trends as its clients had ordered more product from Extreme than needed in the wake of the COVID-19 pandemic to avoid supply shortages and because of a lack of alternative sourcing options and thereby had cannibalized their Class Period purchasing needs; (b) Extreme was increasingly offsetting these adverse organic demand trends with the fulfillment of backlog orders in a manner that materially exceeded the proportion represented to investors; (c) as a result of (a)-(b), Extreme was drawing down its backlog at a much faster rate than represented to investors; (d) as a result of (a)-(c), Extreme's backlog was already decreasing and at a much quicker pace than defendants' statements to investors that backlog would only "begin to shrink" in 4Q23 and it would be not until "fiscal '26 when it really goes back to normal"; (e) as a result of (a)-(d), Extreme's backlog was not on track to continue increasing to $600 million; and (f) as a result of (a)-(e) above, defendants had materially misrepresented Extreme's organic demand, revenue growth, and market share gains as the fulfillment of Extreme's backlog masked a decline in organic demand and attendant revenues.

WHAT'S NEXT? If you suffered a loss in Extreme during the relevant time frame, you have until October 15, 2024 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP


These press releases may also interest you

at 16:10
The Arena Group Holdings, Inc. ("Arena" or the "Company"), a technology platform and media company home to more than 265 brands, today announced that it received a notification ("Letter") on October 2, 2024 from the NYSE American informing the...

at 16:05
Insmed Incorporated , a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today presented positive late-breaking subgroup data from the...

at 16:00
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Metagenomi, Inc. ("Metagenomi" or "the Company") and certain of its officers....

at 15:40
(Family Features) Four and a half years after the start of the COVID-19 pandemic, people are once again enjoying time with friends and family and doing their favorite things. However, the virus that causes COVID-19 keeps changing, so it's still...

at 15:38
(Family Features) Colder weather brings a change in seasons and often an uptick in flu and COVID-19 cases. The viruses that cause COVID-19 and flu keep changing and infecting thousands of people each year, with older adults being most at risk. The...

at 13:25
The "Asia-Pacific DNA Methylation Detection Technology Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The Asia-Pacific DNA methylation detection technology market was valued at $443.6 million in...



News published on and distributed by: